Association Memberships

Celgene is a member of a number of associations that represent the biopharmaceutical sector and the business community in general. These organizations serve a variety of purposes such as speaking with a uniform voice with policymakers on public policy issues or collaborating on education and advocacy activities. Our participation in these associations is grounded in the understanding that we may not always agree with all of the positions taken by the association or its other members. Celgene representatives serve on various boards and committees within these organizations to share Celgene’s perspective on the issues and advocate for policies that advance patient access and innovation in health care.

Celgene also participates with tax-exempt state legislative membership organizations that write and endorse model legislation, including providing support in 2018 to the Council of State Governments ($8,500) and the American Legislative Exchange Council ($21,000.).

NOTE: For U.S. Associations to which Celgene contributed $50,000 or more during 2018, the amount reported to Celgene by the association as non-deductible lobbying expenditures is included.

  • Agipharm (France)
  • Alliance for Regenerative Medicine (US) $30,000
  • American Chamber of Commerce in Belgium (Belgium)
  • American Chamber of Commerce in Spain (Spain)
  • American Chamber of Commerce in the Netherlands (Netherlands)
  • American Chamber of Commerce to the EU (Europe)
  • American Legislative Exchange Council (ALEC)
  • American Pharmaceutical Group, APG (UK)
  • Arbeitsgemeinschaft Therapie Seltene Erkrankungen, ATSE (Germany)
  • Asociación Espa?ola de Bioempresas (Spain)
  • Asociación Nacional Empresarial de la Industria Farmacéutica (Spain)
  • Assobiotec (Italy)
  • Associa??o Portuguesa da Indústria Farmacêutica (Portugal)
  • Association of Innovative Pharmaceutical Industry (Czech Republic)
  • Association of Innovative Pharmaceutical Manufacturers (Hungary)
  • Association of Pharmaceutical Companies “Innovative Pharma” (InPharma) (Russia)
  • Association of the British Pharmaceutical Industry (UK)
  • BIA (The BioIndustry Association)
  • BIO (Biotechnology Innovation Organization) (US) $152,066
  • BIOCOM (California, US)
  • BioNJ (New Jersey, US) $8,500
  • BioOhio (Ohio, US)
  • BIOTECanada (Canada)
  • Biotechnology Industry Association (Portugal)
  • Brazilian Research Based Pharmaceutical Manufacturers Association (Interfarma) (Brazil)
  • Bundesverband der Pharmazeutischen Industrie (Germany)
  • Business Council for International Understanding (US)
  • California Biotechnology Foundation (US)
  • California Life Sciences Association (California, US)
  • CEO Roundtable on Cancer (US)
  • Commerce and Industry Association of New Jersey (New Jersey, US)
  • Council of State Governments (CSG)
  • Employers Union of Innovative Pharmaceutical Companies (Poland)
  • Ethical Medicines Industry Group (UK)
  • European Confederation of Pharmaceutical Entrepreneurs (Europe)
  • European Federation of Pharmaceutical Industries and Associations (Europe)
  • Fair Trade Council of Ethical Pharmaceutical Drug Manufacturing Industry (Japan)
  • Farmindustria, Associazione delle imprese del farmaco (Italy)
  • Federation of Pharmaceutical Manufacturers’ Association of Japan (Japan)
  • Forum der forschenden pharmazeutischen Industrie (Austria)
  • Forum for Innovative Regenerative Medicine (Japan)
  • Forum of International Research and Development Pharmaceutical Industries (Slovenia)
  • Healthcare Institute of New Jersey (New Jersey, US) $41,974
  • HollandBio (Holland)
  • International Research Based Pharmaceutical Manufacturers Association (IRPMA) (Taiwan)
  • Irish Pharmaceutical Healthcare Association (Ireland)
  • Italian American Pharmaceutical Group (IPAG) (Italy)
  • Japan Pharmaceutical Manufacturers Association (JPMA) (Japan)
  • Japan Pharmaceutical Manufacturers’ Association of Tokyo (Japan)
  • Korea Research Based PhRMA Industry Association (KRPIA) (South Korea)
  • Les Entreprises du Medicament (France)
  • Life Science Washington (US)
  • Local American Working Group, LAWG (Germany)
  • Louisiana Association of Business & Industry (US)
  • Medicines Australia (Australia)
  • Mexican Association of Pharmaceutical Research Industries (AMIIF) (Mexico)
  • Minnesota Chamber of Commerce (Minnesota, US)
  • National Pharmaceutical Council (US)
  • New Jersey Chamber of Commerce (New Jersey, US)
  • New York State Business Council (New York, US)
  • Phama.be (Belgium)
  • Pharma Industry Finland, PIF (Finland)
  • Pharmaceutical Association of Malaysia (PhAMA) (Malaysia)
  • Pharmaceutical Research & Manufacturers Association (PreMA) (Thailand)
  • Pharmaceutical Research and Manufacturers of America (PhRMA) (US) $4,975,784
  • Pharmaceutical Research and Manufacturers of America, Japan (PhRMA Japan) (Japan)
  • Pharmig (Austria)
  • Public Affairs Council (Washington, DC, US)
  • R&D Based Pharmaceutical Association (RDPAC) (China)
  • Research and Development Council of NJ
  • Slovak Association of Research Based Pharmaceutical Companies (Slovakia)
  • State Biotechnology Associations in Georgia, Illinois, Iowa, Massachusetts, Missouri, New York, North Carolina, Oregon, Texas, Washington (US)
  • Swedish Association of the Pharmaceutical Industry (Sweden)
  • The Danish Association of the Pharmaceutical Industry, LIF (Denmark)
  • The Medical Alley Association (US)
  • U.S. Chamber of Commerce (US) $136,250
  • US-Japan Business Council (Washington, DC, US)
  • US-Korea Business Council (Washington, DC, US)
  • Verband der forschenden pharmazeutischen Firmen der Schweiz, Interpharma (Switzerland)
  • Vereniging Innovatieve Geneesmiddelen Nederland (Netherlands)
  • Wisconsin Manufacturers and Commerce (Wisconsin, US)